TAGS: Decorative Cosmetic
Based on 2017’s report of asbestos contamination in certain cosmetic products sold by Claire’s and Justice retailers, FDA has conducted independent tests. These tests confirmed the presence of asbestos in three of the product samples collected from Claire’s and one of the product samples collected from Justice.
Safety Alert FOR Consumers
The FDA issued a Safety Alert today warning consumers to not use three of Claire’s products: Claire’s Eye Shadows – Batch No/Lot No: 08/17; Claire’s Compact Powder – Batch No/Lot No: 07/15; and, Claire’s Contour Palette – Batch No/Lot No: 04/17 because they tested positive for asbestos.
FDA strongly encourages consumers and health care providers to report cosmetic-related adverse reactions to the FDA’s MedWatch reporting system or a consumer complaint coordinator.
New Steps to Protect Consumers
FDA has called upon the cosmetic industry to take important new steps. Ultimately, the FDA also seeks to engage with stakeholders to work on other new opportunities to improve the overall framework for assuring the safety of the cosmetic products that consumers use.
It will soon be working with cosmetics manufacturers and requesting information about what procedures they use to ensure their cosmetics are safe and, in particular, about how they ensure that talc used in any cosmetic product is free from asbestos.
Although the law doesn’t require cosmetic products to be registered with the FDA, it is also calling upon cosmetic firms to take responsible steps to voluntarily register their products and list ingredients, including talc, used in their products via the FDA's Voluntary Cosmetic Registration Program (VCRP).
Evaluating Ingredient or Products
FDA will continue evaluating concerns about ingredients or products and will make determinations, based on currently available science, if certain cosmetic ingredients should be prohibited and restricted. Moving forward, it will continue the work uncovering ingredients or products of concern and will take swift action to inform and advise consumers of any identified public health risks.
Source: FDA